CERo Therapeutics Holdings, Inc. Common Stock (CERO)

Official site

HEALTHCARE • BIOTECHNOLOGY • PINK

$0.01

+0.00 (+0.00%)

Market Cap: $436,950

Last updated: Oct 14, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

33%(1/3)

Avg Surprise

-309.86%

Upcoming Estimates

Period ending Jun 30, 2026

EPS Consensus$N/A

Revenue Consensus

Range$0 - $0

0 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26EST	-	N/A	-	-	-	-	-	-
Dec 31, 2025Dec 25 Reported Feb 25, 2026Reported Feb 25	$N/A	$-0.75	$-0.75 - $-0.75	N/A	Beat	1	1 0 30d	-
Sep 30, 2025Sep 25 Reported Nov 19, 2025Reported Nov 19	$-9.10	$-4.35	$-4.35 - $-4.35	-109.20%	Miss	1	No revisions (30d)	+94.7%
Jun 30, 2025Jun 25 Reported Aug 22, 2025Reported Aug 22	$-61.71	$-6.21	$-6.21 - $-6.21	-893.72%	Miss	1	1 0 30d	+79.6%
Mar 31, 2025Mar 25 Reported Apr 1, 2025Reported Apr 1	$-31.80	N/A	-	+73.32%	Beat	-	-	+89.8%
Dec 31, 2024Dec 24 Reported Feb 26, 2025Reported Feb 26	$-17.49	N/A	-	N/A	Beat	-	-	+80.7%
Sep 30, 2024Sep 24 Reported Nov 19, 2024Reported Nov 19	$-170.22	N/A	-	N/A	Beat	-	-	-61.4%
Jun 30, 2024Jun 24 Reported Aug 14, 2024Reported Aug 14	$-302.32	N/A	-	N/A	Beat	-	-	+28.0%
Mar 31, 2024Mar 24 Reported Mar 31, 2024Reported Mar 31	$-312.74	N/A	-	N/A	Beat	-	-	-119.7%
Dec 31, 2023Dec 23 Reported Mar 29, 2024Reported Mar 29	$-90.54	N/A	-	N/A	Beat	-	-	-905281.0%
Sep 30, 2023Sep 23 Reported Dec 29, 2023Reported Dec 29	$-105.50	N/A	-	N/A	Beat	-	-	-1534.5%
Jun 30, 2023Jun 23 Reported Sep 28, 2023Reported Sep 28	$-419.78	N/A	-	N/A	Beat	-	-	-4223.4%
Mar 31, 2023Mar 23 Reported Jun 29, 2023Reported Jun 29	$-142.32	N/A	-	N/A	Beat	-	-	-711486.5%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$-0.01	N/A	-	N/A	Beat	-	-	+0.0%
Sep 30, 2022Sep 22 Reported Dec 29, 2022Reported Dec 29	$7.35	N/A	-	N/A	Beat	-	-	+73643.0%
Jun 30, 2022Jun 22 Reported Sep 28, 2022Reported Sep 28	$-9.71	N/A	-	N/A	Beat	-	-	-
Mar 31, 2022Mar 22 Reported Jun 28, 2022Reported Jun 28	$-0.02	N/A	-	N/A	Beat	-	-	-
Dec 31, 2021Dec 21 Reported Mar 29, 2022Reported Mar 29	$-0.01	N/A	-	N/A	Beat	-	-	-
Sep 30, 2021Sep 21 Reported Dec 29, 2021Reported Dec 29	$-0.01	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	0.00%	ROIC	39.43%
Financial Health
Debt/Equity	-0.02x	Interest Coverage	-10.16x
Current Ratio	0.05x	Quick Ratio	0.05x
Trading Statistics
Beta	0.22	Avg Volume	661.87K
52-Week High	$2.58	52-Week Low	$0.01

Technical Indicators Dashboard

Moving Averages

SMA 10$0.01

SMA 20$0.01

SMA 50$0.01

SMA 200$0.03

EMA 10$0.01

EMA 20$0.01

EMA 50$0.01

EMA 200$0.82

MACD

Line: -0.00Signal: -0.00Hist: -0.00

ADX

ADX: 14.7+DI: 11.9-DI: 24.3

Aroon & PSAR

Aroon UpN/A

Aroon Down100.0

PSAR$0.01

Bollinger Bands

Upper Band$0.01

Lower Band$0.01

%B Position6213%(Upper)

Band Width0.02

RSI (14-Day)

Neutral

33.5

Momentum Oscillators

Stoch %K14.9

Stoch %D11.0

Williams %R-71.4

ROC (10d)-33.3%

Momentum-0.00

CCI (20d)-211.5

MFI (14d)10.9

Volatility Measures

ATR (14d)$0.00(25.9%)

StdDev (20d)0.00

Hist Vol112.1%(High)

Volume Flow

VWAP$0.01

OBV11.9M

AD Line19.5B

CMF (20d)-0.274

Volume Metrics

Avg Vol (20d)701.8K

Vol Ratio1.9x(High)

VWMA (20d)$0.01

Pivot Points

R3$0.01

R2$0.01

R1$0.01

Pivot Point$0.01

S1$0.01

S2$0.01

S3$0.00

Advanced Oscillators

TSI-17.52

Ultimate Osc39.6

KST-158.74

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Total Revenue	$0	$0	N/A	$0	$0	$0	$0	$0	N/A	$0	$0	$0
Cost of Revenue	$0	$0	N/A	$0	$0	$0	$0	$0	$288,161	$284,751	$0	$0
Gross Profit	$0	$0	N/A	$0	$0	$0	$0	$0	$-288,161	$-284,751	$0	$0

Operating Expenses	$3.85M	$4.85M	$4.43M	$4.36M	$4.72M	$4.95M	$4.40M	$5.15M	$4.26M	$1.35M	$1.54M	$2.41M
R&D	$1.74M	$2.34M	$2.33M	$2.39M	$2.75M	$2.91M	$1.77M	$2.71M	$1.38M	$1.02M	$1.28M	$1.19M
SG&A	$2.11M	$2.51M	$2.09M	$1.98M	$1.97M	$2.04M	$2.63M	$2.43M	$2.88M	$331,629	$258,013	$1.22M
Operating Income	$-3,846,466	$-4,845,728	$-4,426,248	$-4,362,579	$-4,723,791	$-4,950,531	$-4,402,238	$-5,148,237	$-4,552,070	$-1,287,386	$-1,535,571	$-2,413,746

Interest Income	$1,025	$3,149	$-8,948	$5,936	$13,776	$850	$4,418	$-16,977	$0	$0	$0	$0
Interest Expense	$690,044	$166,286	$114,373	$500,000	$0	$0	$0	$0	$9,629	$-78,750	$-157	$-59,417
Income Before Tax	$-1,028,830	$-5,885,914	$-4,540,621	$-4,856,395	$-5,417,315	$-5,105,931	$-4,227,967	$-2,448,654	$-2,299,694	$-1,347,227	$-1,349,347	$-2,092,507
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$-1	$0	$0	$0

Net Income	$-1,028,830	$-5,885,914	$-4,540,621	$-4,856,395	$-5,417,315	$-5,105,931	$-4,227,967	$-2,448,654	$-2,299,694	$-1,409,393	$-1,349,347	$-2,092,507

EBITDA	$114,130	$-5,309,870	$-4,150,118	$-4,089,565	$-5,554,851	$-4,837,306	$-4,232,385	$-2,431,677	$-2,001,904	$-1,141,226	$-1,068,092	$-1,874,473
EBIT	$-339,811	$-5,722,777	$-4,426,254	$-4,362,331	$-5,431,091	$-5,106,781	$-4,232,385	$-2,431,677	$-2,290,065	$-1,425,977	$-1,349,504	$-2,151,924

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CERO

News

No news available

Company news will appear here when available

CERO Valuation and Fair Value

P/B: -0.0x

See GNG's fair value

CERO Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: 39.4%
ROE: 0.0%

CERO Competitors

Company	Ticker
Venus Concept Inc	VERO
Tivic Health Systems Inc	TIVC
Profusa, Inc. Common Stock	PFSA
Salarius Pharmaceuticals Inc	SLRX
SAB Biotherapeutics Inc	SABSW
Inotiv Inc	NOTV
GlucoTrack Inc	GCTK
Safeplus International Holdings Limited	BIPH

Sector: Healthcare

CERO Bull Case vs Bear Case

Bull case

CERO earns a 39.4% return on invested capital.

CERO Earnings: Beat Rate and Next Report

Beat rate: 1 of 4 quarters (25.0%)
Average surprise: -309.9%

Frequently Asked Questions About CERO

Does CERO pay dividends?

CERo Therapeutics Holdings, Inc. Common Stock (CERO) does not currently pay a regular dividend.

What is CERO's market cap?

CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a market capitalization of $436,950 with a current stock price of $0.01.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In